Fasikl Inc.

Fasikl Inc. is a neurotechnology company developing AI-based therapeutic devices for neurological conditions. The company's flagship product, Felix NeuroAI™ Wristband, is a non-invasive wearable device that has received FDA clearance for the treatment of essential tremor. Felix operates through advanced AI technologies that decode and modulate neural signals, delivering all-day symptomatic relief without surgery or medication. The device represents a breakthrough in AI therapeutics, combining cloud-based artificial intelligence with real-time neural signal processing. Fasikl also develops the Fasikl-X™ Nerve-Computer Interface platform for broader neural interfacing applications. The company has invested over 20 years of R&D in neural signal processing and AI-driven treatment modalities. Products are designed for direct patient use and clinical settings, with support for both individual patients and healthcare providers. FDA clearance indicates regulatory approval for the Felix device as a Class II or higher medical device. The company targets essential tremor patients and related neurological indications, positioning itself at the intersection of wearable medical devices, neurotechnology, and artificial intelligence therapeutics.